Pablo Guzman Power - 26 Jan 2023 Form 4 Insider Report for ZyVersa Therapeutics, Inc. (ZVSA)

Role
Chief Medical Officer
Signature
/s/ Pablo Guzman
Issuer symbol
ZVSA
Transactions as of
26 Jan 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2023, 19:25:12 UTC
Next filing
15 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVSA Stock Options (right to buy) Award $0 +100,000 $0.000000 100,000 26 Jan 2023 Common Stock 100,000 $2.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 3 equal annual installments commencing on January 26, 2024.